» Articles » PMID: 32565744

Dosimetric Comparison of Dynamic Conformal Arc Integrated with Segment Shape Optimization and Variable Dose Rate Versus Volumetric Modulated Arc Therapy for Liver SBRT

Overview
Specialty Oncology
Date 2020 Jun 23
PMID 32565744
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim is a dosimetric comparison of dynamic conformal arc integrated with the segment shape optimization and variable dose rate (DCA_SSO_VDR) versus VMAT for liver SBRT and interaction of various treatment plan quality indices with PTV and degree of modulation (DoM) for both techniques.

Material: Twenty-five patients of liver SBRT treated using the VMAT technique were selected. DCA_SSO_VDR treatment plans were also generated for all patients in Monaco TPS using the same objective constraint template and treatment planning parameters as used for the VMAT technique. For comparison purpose, organs at risk (OARs) doses and treatment plans quality indices, such as maximum dose of PTV (D%), mean dose of PTV (D%), maximum dose at 2 cm in any direction from the PTV (D%), total monitor units (MU's), gradient index R, degree of modulation (DoM), conformity index (CI), homogeneity index (HI), and healthy tissue mean dose (HTMD), were compared.

Results: Significant dosimetric differences were observed in several OARs doses and lowered in VMAT plans. The D%, R, CI, HI and HTMD are dosimetrically inferior in DCA_SSO_VDR plans. The higher DoM results in poor dose gradient and better dose gradient for DCA_SSO_VDR and VMAT treatment plans, respectively.

Conclusions: For liver SBRT, DCA_SSO_VDR treatment plans are neither dosimetrically superior nor better alternative to the VMAT delivery technique. A reduction of 69.75% MU was observed in DCA_SSO_VDR treatment plans. For the large size of PTV and high DoM, DCA_SSO_VDR treatment plans result in poorer quality.

Citing Articles

Is an all-phase ITV (internal target volume) a gold standard in the target definition of hepatocellular carcinoma?.

Kumar R, Gupta A, Vishwanathan B, Kamal R, Thaper D J Appl Clin Med Phys. 2024; 25(12):e14532.

PMID: 39284228 PMC: 11633802. DOI: 10.1002/acm2.14532.


Modeling of Gamma Index for Prediction of Pretreatment Quality Assurance in Stereotactic Body Radiation Therapy of the Liver.

Kamal R, Thaper D, Singh G, Sharma S, Navjeet , Oinam A J Med Phys. 2024; 49(2):232-239.

PMID: 39131435 PMC: 11309143. DOI: 10.4103/jmp.jmp_176_23.


Feasibility and dosimetric evaluation of single- and multi-isocentre stereotactic body radiation therapy for multiple liver metastases.

Tang C, Gong C, Liu B, Guo H, Dai Z, Yuan J Front Oncol. 2023; 13:1144784.

PMID: 37188200 PMC: 10175834. DOI: 10.3389/fonc.2023.1144784.


Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor.

Watcharawipha A, Chakrabandhu S, Kongsa A, Tippanya D, Chitapanarux I J Appl Clin Med Phys. 2023; 24(7):e13948.

PMID: 36857202 PMC: 10338832. DOI: 10.1002/acm2.13948.


Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study.

Mesny E, Ayadi M, Dupuis P, Beldjoudi G, Tanguy R, Martel-Lafay I Radiat Oncol. 2023; 18(1):36.

PMID: 36814265 PMC: 9948312. DOI: 10.1186/s13014-023-02227-2.


References
1.
Verbakel W, Senan S, Cuijpers J, Slotman B, Lagerwaard F . Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol. 2009; 93(1):122-4. DOI: 10.1016/j.radonc.2009.05.020. View

2.
Sarkar B, Manikandan A, Nandy M, Munshi A, Sayan P, Sujatha N . Influence of monte carlo variance with fluence smoothing in VMAT treatment planning with Monaco TPS. Indian J Cancer. 2016; 53(1):158-61. DOI: 10.4103/0019-509X.180820. View

3.
Kubo K, Monzen H, Tamura M, Hirata M, Ishii K, Okada W . Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer. J Appl Clin Med Phys. 2018; 19(2):121-127. PMC: 5849850. DOI: 10.1002/acm2.12264. View

4.
Molinier J, Kerr C, Simeon S, Ailleres N, Charissoux M, Azria D . Comparison of volumetric-modulated arc therapy and dynamic conformal arc treatment planning for cranial stereotactic radiosurgery. J Appl Clin Med Phys. 2016; 17(1):92-101. PMC: 5690199. DOI: 10.1120/jacmp.v17i1.5677. View

5.
Masi L, Doro R, Favuzza V, Cipressi S, Livi L . Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy. Med Phys. 2013; 40(7):071718. DOI: 10.1118/1.4810969. View